Management of Amoxicillin-Associated Rashes

Patient Assessment and Treatment

For patients with mild maculopapular rash, treatment includes discontinuation of amoxicillin if the rash is bothersome, oral antihistamines, topical corticosteroids, and acetaminophen or ibuprofen for associated fever or discomfort, as recommended by Praxis Medical Insights 1
Patients with infectious mononucleosis have a 30-100% chance of developing a non-pruritic morbilliform rash when given amoxicillin, which is not a true allergy but rather a unique interaction between the virus and medication, according to Praxis Medical Insights 1
The American Academy of Otolaryngology-Head and Neck Surgery suggests considering switching to a non-beta-lactam antibiotic for patients with mild maculopapular rash who are being treated for an active infection 2

Patients with severe reactions, such as anaphylaxis, Stevens-Johnson syndrome, or toxic epidermal necrolysis, should avoid penicillins and undergo formal allergy evaluation, as recommended by the Journal of Allergy and Clinical Immunology 3
The Journal of Allergy and Clinical Immunology recommends documenting the reaction in the medical record and considering allergy consultation for clarification of true allergy status 3

The guideline for acute sore throat notes that amoxicillin is a poor first choice in older children specifically because of the risk of severe rash among patients with Epstein-Barr virus infection 4

If a patient has a documented severe reaction, they should avoid first and second generation cephalosporins as well, as cross-reactivity exists 5

The American Academy of Allergy, Asthma, and Immunology recommends immediately discontinuing amoxicillin and seeking emergency evaluation if anaphylaxis, angioedema, or severe cutaneous adverse reactions occur 6
The American Academy of Allergy, Asthma, and Immunology suggests that patients with a history of severe reactions should avoid all penicillins permanently and avoid first- and second-generation cephalosporins due to cross-reactivity 6
Third-generation cephalosporins with dissimilar R1 side chains may be used with caution or after allergy consultation, as recommended by the American Academy of Allergy, Asthma, and Immunology 6

The American Academy of Allergy, Asthma, and Immunology recommends a direct oral amoxicillin challenge for patients with a history of benign maculopapular rash when they next require antibiotics 6
Patients with low-risk criteria, such as a reaction occurring >1 year ago, benign maculopapular rash or urticaria without systemic symptoms, and no anaphylaxis or severe cutaneous reactions, can undergo a direct challenge without skin testing, as recommended by the American Academy of Allergy, Asthma, and Immunology 6